Collegium Appoints Neil McFarlane to its Board of Directors STOUGHTON, Mass., April 06, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced…
LTENApril 7, 2022